Markets:

Overview

News

Currencies

International

Treasuries

Cronos Group Inc. - Common Share (NQ:CRON)

2.500 -0.010 (-0.40%)

Streaming Delayed Price Updated: 12:20 PM EST, Feb 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cronos Group Inc. - Common Share

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

40 41 Next >

Analysts' Take Brought To You On Monday's Cannabis Daily Podcast ↗

March 07, 2022

The Best Daily Overview Of The Cannabis Space Village Farms Intl (NASDAQ:

Via Benzinga

The Canadian Cannabis Report - Monday, Mar. 7 ↗

March 07, 2022

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

Via Talk Markets

Cannabis Stocks In Freefall, Down -25.6% This Week ↗

March 05, 2022

Our Pure-Play

Via Talk Markets

Cannabis Chart Of The Week: Are You Worth More Than Your Cash? Cash-To-Market Cap Ratios Among Weed Companies ↗

March 01, 2022

The graph depicts the ratio of cash to market cap for the U.S. and Canadian Cultivation & Retail companies with more than $200M o...

Via Benzinga

Recap: Cronos Group Q4 Earnings ↗

March 01, 2022

Cronos Group (NASDAQ:CRON) reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Earnings Scheduled For March 1, 2022 ↗

March 01, 2022

Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...

Via Benzinga

Cronos Group Earnings Preview ↗

February 28, 2022

Cronos Group (NASDAQ:CRON) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Cronos Group Q3 Financial Results Show Major Improvement ↗

February 19, 2022

Cronos Group, a constituent in our Pure-Play Pot Stock Index, yesterday reported markedly improved Q3 financials for the period ending September 30,

Via Talk Markets

Cronos Q3 Revenue Grows 79% YoY To $20.4M, Audit Committee Completes Evaluation ↗

February 18, 2022

Cronos Group Inc. (NASDAQ:CRON) (TSX:

Via Benzinga

Cronos Group Reports 59% YoY Revenue Increase In FY 2021, Plans To Exit Of Peace Naturals Campus In Stayner, ON ↗

March 01, 2022

Cronos Group Inc. (NASDAQ:CRON) (TSX:

Via Benzinga

Thinking About Buying Stock In Pieris Pharmaceuticals, Baidu Or Cronos Group? ↗

February 28, 2022

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings b...

Via Benzinga

7 Best Stocks to Buy for a Recession ↗

February 25, 2022

These low-beta recession stocks to buy have robust cash flows to sustain their businesses while paying regular dividends.

Via InvestorPlace

10 Biggest Price Target Changes For Tuesday ↗

February 22, 2022

Wells Fargo lowered DraftKings Inc. (NASDAQ: DKNG) price target from $41 to $19. DraftKings shares dropped 5.8% to $16.28 in pre-market trading.

Via Benzinga

"Seed-To-Sale" Pot Stocks Index Faltered This Past Week After Two-Week Resurgence ↗

February 21, 2022

Unfortunately, the turnaround in cannabis stocks did not hold, with the index dropping -5.5% this past week.

Via Talk Markets

Cronos Group Provides Bi-Weekly MCTO Status Update ↗

February 14, 2022

Cronos Group Inc. (NASDAQ:CRON) (TSX:

Via Benzinga

The Canadian Cannabis Report- Monday, Feb. 21 ↗

February 21, 2022

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

Via Talk Markets

Lost Money in Cronos Group, Inc.?

February 18, 2022

From Gibbs Law Group

Via Business Wire

Global Cannabis Extract Market To Surpass $38B By 2030, Key Players Include Tilray, Canopy Growth, Aurora ↗

February 17, 2022

According to Coherent Market Insights, the global cannabis extract market is estimated to be valu...

Via Benzinga

NASDAQ:CRON Shareholder Notice: Investigation over Potential Wrongdoing at Cronos Group Inc. ↗

February 16, 2022

San Diego, CA -- (SBWIRE) -- 02/16/2022 -- Certain directors of Cronos Group Inc. are under investigation over potential breaches of fiduciary duties by certain officers and directors at Cronos Group...

Via SBWire

Lost Money in Cronos Group, Inc.?

February 14, 2022

From Gibbs Law Group

Via Business Wire

Cannabis Stocks Are Up For The Second Week In A Row ↗

February 12, 2022

Almost all the largest cap

Via Talk Markets

7 Tempting Sin Stocks to Profit From the Pandemic’s Most Popular Vices ↗

February 09, 2022

After the recent market decline, investors are discovering that vices may not a bad thing to invest in. Here are 7 top sin stocks to buy now.

Via InvestorPlace

Cannabis Stocks Have Bounced Back From Last Week's 52-Week Lows ↗

February 05, 2022

All the largest cap

Via Talk Markets

Cannabis Stock Gainers And Losers From February 1, 2022 ↗

February 01, 2022

GAINERS: MedMen Enterprises (OTC:MMNFF) shares closed up 58.51% at $0.16

Via Benzinga

New Kids On The Block: Is A Second Wave Of Canadian Cannabis Here? ↗

February 01, 2022

Cannara’s Valleyfield Facility This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Cannabis Stock Gainers And Losers From January 31, 2022 ↗

January 31, 2022

GAINERS: Greenlane Hldgs (NASDAQ:GNLN) shares closed up 18.20% at $0.76

Via Benzinga

Most Cannabis Stocks Have Descended Below Their Previous 52-Week Lows ↗

January 29, 2022

Is now the time to buy one or two of the deeply discounted cannabis stocks? The majority of them are now trading at new lows.

Via Talk Markets

Cannabis Stock Gainers And Losers From January 28, 2022 ↗

January 28, 2022

GAINERS: BioHarvest Sciences (OTC:CNVCF) shares closed up 19.61% at $0.33

Via Benzinga

Cannabis Stock Gainers And Losers From January 27, 2022 ↗

January 27, 2022

GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 8.27% at $0.03

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022 ↗

January 27, 2022

Upgrades

Via Benzinga

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

40 41 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.